On Invalid Date, Gsk (NYSE: GSK) reported Q1 2024 earnings per share (EPS) of $0.66, up 25.7% year over year. Total Gsk earnings for the quarter were $1.34 billion. In the same quarter last year, Gsk's earnings per share (EPS) was $0.89.
As of Q2 2024, Gsk's earnings has grown -67.61% year over year. This is 87.46 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 19.84%. Gsk's earnings in the past year totalled $5.54 billion.
What was GSK's revenue last quarter?
On Invalid Date, Gsk (NYSE: GSK) reported Q1 2024 revenue of $9.44 billion up 12.72% year over year. In the same quarter last year, Gsk's revenue was $8.37 billion.
What was GSK's revenue growth in the past year?
As of Q2 2024, Gsk's revenue has grown 12.47% year over year. This is 3.6 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 8.86%. Gsk's revenue in the past year totalled $37.95 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.